Search results
- Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Sir David Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020.
en.wikipedia.org/wiki/Haleon
People also ask
Who owns haleon?
What happened to haleon?
What happened to GSK & haleon?
What happened to Haleon plc (GSK) in 2022?
When was Haleon formed?
When did haleon & GSK merge?
Aug 10, 2022 · Who owns Haleon shares? There are a number of significant shareholders of Haleon, according to Keith Bowman, senior equity analyst at interactive investor. “US drugs company Pfizer remains Haleon’s biggest shareholder at around 32%, having held an interest in GSK before Haleon’s recent demerger,” he said.
- Rob Griffin
- 237, 28th October Street, Limassol, Cyprus, 3035
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6] Sir David Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.
Jul 18, 2022 · GSK plc (LSE/NYSE: GSK) has today (Monday 18 July 2022) completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group.
Feb 29, 2024 · Feb 29 (Reuters) - Haleon (HLN.L) plans to buy back 500 million pounds ($633 million) of its shares this year amid firm demand for its products and progress in reducing debt, sending the...
- Eva Mathews
Feb 22, 2022 · Haleon will be a new world-leader in consumer health with an exceptional portfolio of category-leading brands, including Sensodyne, Voltaren, Panadol and Centrum. Business is on track to demerge and list as a new company in mid-2022.
Jul 18, 2022 · Haleon, the consumer healthcare company behind brands such as Sensodyne and Aquafresh toothpaste, Centrum vitamins, Voltaren, Panadol and Advil painkillers, Tums heartburn tablets and Nicorette smoking cessation products, was valued at £31bn when it took its stock market bow on Monday morning.
Jun 1, 2022 · On Monday 18 July 2022, GSK plc (“GSK” or the “Company”) separated its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company.
